(ALLO) Allogene Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Allogene Therapeutics | (ALLO) share price targets
Complete technical analysis of Allogene Therapeutics (ALLO) by charts plus indicators, forecast predictions and share price targets for Allogene Therapeutics (ALLO)
Allogene Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Allogene Therapeutics is 4307289
Date | Daily Closing Price | Open | High | Low | Volume |
01 Fri Aug 2025 | 1.08 | 1.23 | 1.23 | 1.00 | 4.431 times |
31 Thu Jul 2025 | 1.23 | 1.29 | 1.32 | 1.22 | 1.36 times |
30 Wed Jul 2025 | 1.29 | 1.44 | 1.50 | 1.27 | 2.149 times |
29 Tue Jul 2025 | 1.40 | 1.47 | 1.48 | 1.39 | 0.463 times |
28 Mon Jul 2025 | 1.47 | 1.49 | 1.53 | 1.45 | 0.524 times |
25 Fri Jul 2025 | 1.50 | 1.52 | 1.54 | 1.45 | 0.648 times |
24 Thu Jul 2025 | 1.51 | 1.65 | 1.69 | 1.49 | 0.891 times |
23 Wed Jul 2025 | 1.66 | 1.45 | 1.69 | 1.43 | 1.636 times |
22 Tue Jul 2025 | 1.42 | 1.33 | 1.42 | 1.31 | 0.673 times |
21 Mon Jul 2025 | 1.32 | 1.25 | 1.36 | 1.25 | 0.796 times |
Stock of Allogene Therapeutics (ALLO) has showed a significant fall. This could be a good time to exit from this stock.
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 1.2, but if it comes above 1.2, then a intra day buy could be more profitable.
If you take a sell trade below 1.2, then use 1.2 as stoploss and 1 as target. However if you take a buy trade in stock , then use 1.2 as stoploss and 1.31 as target.
Share price targets for Allogene Therapeutics (ALLO)
Target Type | Value |
Downside Target | 0.86 |
Downside Target | 1.00 |
Upside Target | 1.11 |
Upside Target | 1.21 |
Upside Target | 1.29 |
Upside Target | 1.33 |
Upside Target | 1.35 |
Upside Target | 1.51 |
Upside Target | 1.53 |
Upside Target | 1.69 |
Upside Target | 1.70 |
Upside Target | 1.78 |
Intraday share price targets for Allogene Therapeutics (ALLO)
Target Type | Value |
Downside Intraday Target | 0.88 |
Downside Intraday Target | 0.67 |
Upside Intraday Target | 1.41 |
Upside Intraday Target | 1.73 |
Upside Intraday Target | 1.2 |
Weekly technical analysis of Allogene Therapeutics (ALLO)
Date | Weekly Closing Price | Open | High | Low | Volume |
01 Fri Aug 2025 | 1.08 | 1.49 | 1.53 | 1.00 | 1.922 times |
25 Fri Jul 2025 | 1.50 | 1.25 | 1.69 | 1.25 | 1.805 times |
18 Fri Jul 2025 | 1.25 | 1.27 | 1.35 | 1.21 | 0.421 times |
11 Fri Jul 2025 | 1.28 | 1.22 | 1.33 | 1.13 | 2.499 times |
03 Thu Jul 2025 | 1.19 | 1.18 | 1.29 | 1.11 | 0.732 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Allogene Therapeutics (ALLO)
Date | Monthly Closing Price | Open | High | Low | Volume |
01 Fri Aug 2025 | 1.08 | 1.23 | 1.23 | 1.00 | 0.224 times |
31 Thu Jul 2025 | 1.23 | 1.13 | 1.69 | 1.11 | 1.667 times |
30 Mon Jun 2025 | 1.13 | 1.19 | 1.51 | 1.12 | 0.617 times |
30 Fri May 2025 | 1.17 | 1.67 | 1.78 | 0.86 | 1.55 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Allogene Therapeutics (ALLO)
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Allogene Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Allogene Therapeutics in short term and the sell signal is strong.
Allogene Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Allogene Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Allogene Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.3 and Allogene Therapeutics (ALLO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Allogene Therapeutics (ALLO) stock. Volume based technical analysis of Allogene Therapeutics (ALLO) stock is negative.
Allogene Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Allogene Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Allogene Therapeutics in short term and the sell signal is strong.
Allogene Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Allogene Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Allogene Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.3 and Allogene Therapeutics (ALLO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Allogene Therapeutics (ALLO) stock. Volume based technical analysis of Allogene Therapeutics (ALLO) stock is negative.
Allogene Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.